Modern methods of identification of adverse events associated with medication errors

Modern methods of identification of adverse events associated with medication errors

Prevention of adverse events caused by medication errors is an important challenge of modern healthcare as it offers the possibility to reduce mortality, improve patient safety and reduce costs arosed from correction of complications. Two modern methods (Global Trigger Tool and Failure Mode and Effe...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. P. Pereverzev, S. K. Zyryanov, Y. Sh. Guschina
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Безопасность и риск фармакотерапии
Subjects:	ошибки лекарственные препараты нежелательные явления adverse events errors medications
Online Access:	https://www.risksafety.ru/jour/article/view/56
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

АНАЛИЗ РАСПРОСТРАНЕННОСТИ И ТИПОВ ПОБОЧНЫХ РЕАКЦИЙ НА ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ
by: Ирада АХУНДОВА, et al.
Published: (2025-04-01)

CORRECTION of erasures by codes with parity check symbol based on IDENTIFICATION of multiplicity of error in forward and inverse decoding channels
by: N. A. Salas, et al.
Published: (2019-06-01)

Socio-economic aspects of medical errors and their consequences in medical organizations
by: O. L. Zadvornaya, et al.
Published: (2019-04-01)

Epidemiology of Medical Errors and Incidents in Emergency Medicine
by: Yu. E. Voskanyan
Published: (2022-09-01)

Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023
by: Saleh F. Alqifari, et al.
Published: (2025-07-01)

Adverse events of modern antifungal drugs during treatment of invasive fungal infections
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Analysis of human errors in nuclear power plant event reports
by: Meihui Zhang, et al.
Published: (2025-10-01)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016-06-01)

Specifics of herbal drugs quality testing with the examples of typical criticism of laboratory testing of those
by: N. P. Antonova, et al.
Published: (2018-02-01)

Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
by: Zhuomiao Lin, et al.
Published: (2025-08-01)

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
by: Yuan-Yuan Wu, et al.
Published: (2025-05-01)

Neurological adverse events associated with baclofen: a pharmacovigilance study based on FDA adverse event reporting system
by: Yunhan Zhao, et al.
Published: (2025-05-01)

Osimertinib-related myotoxicity: a disproportionality analysis of the FDA adverse event reporting system
by: Yaqian Tan, et al.
Published: (2025-08-01)

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
by: Kristine M. Erlandson, MD, MS, et al.
Published: (2025-09-01)

Comprehensive safety analysis of adverse events associated with eptinezumab in migraine treatment
by: Junchen Chen, et al.
Published: (2025-07-01)

THE ALGORITHM FOR CALCULATING THE PROBABILITY OF ERROR IN FADING RADIO CHANNELS USING THE METHOD OF ROTATION
by: Vladimir Petrovich Pashincev, et al.
Published: (2022-05-01)

ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database
by: Yu Liu, et al.
Published: (2025-08-01)

Postmarketing adverse events associated with onasemnogene abeparvovec: a real-world pharmacovigilance study
by: Tianyu Chen, et al.
Published: (2025-05-01)

Prevalence of Adverse Events and Hypoglycemia in Patients with Type 2 Diabetes Treated with Novel Antidiabetic Medications
by: Ebrahim Mohammadi, et al.
Published: (2025-03-01)

Development of lactation and breast/chestfeeding adverse event terminology (LaBAET) through a Delphi consensus approach
by: Katarzyna M. Maksym, et al.
Published: (2025-07-01)

The evolution of discussion ideas on drug-induced disease
by: Yu. V. Muravyev, et al.
Published: (2016-10-01)

Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system
by: Chufeng Ding, et al.
Published: (2025-04-01)

A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system
by: Miao Liu, et al.
Published: (2025-08-01)

Incidence of postoperative respiratory adverse events and its predictors among pediatric surgical patients at Hawassa University Comprehensive Specialized Hospital: a prospective follow-up study
by: Tesfaye Asefa Hordofa, et al.
Published: (2025-05-01)

The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Yutong Wu, et al.
Published: (2025-05-01)

Reliability as a criterion of efficiency of diagnostics of transport and technological machines
by: Aleksej Nikolaevich Cheboksarov
Published: (2017-08-01)

ICD-10 Codes to Identify Adverse Drug Events Associated with Antibiotics in Administrative Data
by: Hannah Lishman, et al.
Published: (2025-03-01)

First available biosimilar monoclonal antibodies
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

Relevant issues of testing quality of drugs in the form of tablets
by: E. L. Kovaleva, et al.
Published: (2018-02-01)

Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use
by: A. V. Matveev, et al.
Published: (2021-11-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Using telemedicine technologies as a tool for monitoring adverse events in patients with chronic hepatitis C receiving antiviral therapy
by: A. O. Bueverov, et al.
Published: (2024-07-01)

Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database
by: Xinkuo Zheng, et al.
Published: (2025-08-01)

Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population
by: Shailendra Kumar Karn, et al.
Published: (2025-05-01)

Microbiota γ‐Butyrobetaine Is Associated With Increased Risk of Major Adverse Limb Events in People With Lower Extremity Arterial Disease Undergoing Endovascular Therapy
by: Zheng‐Wei Chen, et al.
Published: (2025-08-01)

Influence social and healthcare support on psychiatric adverse events in MDR-TB patient
by: Reviono Reviono, et al.
Published: (2018-07-01)

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases
by: Tao Wang, et al.
Published: (2025-04-01)

Adverse Events Associated with Apremilast and Deucravacitinib for Psoriasis: A Pharmacovigilance Study Based on the FAERS Database
by: Xu Y, et al.
Published: (2025-05-01)

Incidence and outcome characteristics of adverse event in surgery: an assessment based on systematic reviews of barbed suture
by: Xianlin Gu, et al.
Published: (2025-07-01)